|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.063 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 484,718 | 10.084% | 440,316 | 353,405 | 208,776 | 209,449 |
| Cost of Sales | (91,900) | -12.836% | (105,433) | (76,398) | (27,682) | (27,932) |
| Gross Profit | 392,818 | 17.300% | 334,883 | 277,007 | 181,094 | 181,517 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 18,777 | |
| Other Non-operating Items | -- | -- | (2,307) | (15,610) | -- | 46,427 | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 75,900 | 75.341% | 43,287 | (20,012) | (70,941) | 5,140 | |
| Taxation | (5,024) | 5.215% | (4,775) | 421 | (378) | (2,681) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 70,876 | 84.036% | 38,512 | (19,591) | (71,319) | 2,459 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (567) | -38.436% | (921) | 6 | (425) | (64) |
| Depreciation & Amortisation | 16,882 | -3.784% | 17,546 | 20,850 | 20,920 | 21,487 |
| Directors' Emoluments | 3,259 | 5.777% | 3,081 | 4,540 | 8,291 | 5,458 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 1.110 | 81.967% | 0.610 | -0.310 | -1.110 | 0.040 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.016 | -- | 0.008 | 0.002 | (0.002) | (0.005) |
| NBV per share ($) | 0.040 | -- | 0.031 | 0.027 | 0.030 | 0.038 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 67,382,000 |
| %Change | 71.016% |
| EPS / (LPS) | HKD 0.011 |
| NBV Per Share ($) | HKD 0.051 |